Chairman
Guardant Health, Inc. (GH)Board Member
Guardant Health, Inc. (GH)Equibles does not estimate personal net worth.
Get an email with a short summary when Guardant Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get GH alertsHelmy Eltoukhy is recorded as Chairman at Guardant Health, Inc. (GH) since August 5, 2021, Board Member at Guardant Health, Inc. (GH) since January 1, 2013 and CEO at Guardant Health, Inc. (GH). The newest filing on record that lists Helmy Eltoukhy as CEO and Board Member at Guardant Health, Inc. (GH) is dated April 28, 2026. The proxy statement of Guardant Health, Inc. reports total compensation of $11,591 for Helmy Eltoukhy in fiscal 2023, including a base salary of $1. Disclosed compensation is on record for 7 fiscal years. Helmy Eltoukhy has spoken on 25 earnings calls and 4 other investor events across 1 company, most recently for Guardant Health, Inc. on November 5, 2026. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Guardant Health, Inc. includes AmirAli Talasaz (CEO and Board Member), Michael Bell (CFO), Ines Dahne-Steuber (COO) and 7 others.
“And thank you for joining our third quarter 2026 earnings call. At Garden, our mission is to conquer cancer with data, and the third quarter showed that strategy working across the company.”
“We have these three overlapping S-curves, very large market opportunities that are all growing very rapidly. We had great growth with Garden360 in our oncology business.”
“Yeah, we're really excited about But what we saw in the quarter in terms of oncology volumes, obviously, we had a tremendous sort of volume ramp that we saw. And it was really broad-based in terms of the beat.”
“Good morning and welcome to the 2026 Annual Meeting of Garden Health, Inc. I'm Helmi Oltouki, Co-Chief Executive Officer, Chairperson, and Co-Founder of GARDENT.”
“Yeah, I mean, I think it's been exciting to see us sort of lean into the three S-curves that we're embarking on in terms of utilization and adoption.”
2021-08-05–present
2013-01-01–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
Diagnostics & Research · Healthcare
CEO, Chairman, Board Member
2013-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Guardant Health, Inc. (GH) | Chairman and Co-Chief Executive Officer | $1 | $11,591 |
| 2022 | Guardant Health, Inc. (GH) | Chairman and Co-Chief Executive Officer | $1 | $11,632 |
| 2021 | Guardant Health, Inc. (GH) | Chairman and Co-Chief Executive Officer | $1 | $13,665 |
| 2020 | Guardant Health, Inc. (GH) | Chairman and Co-Chief Executive Officer | $209,937 | $113,870,986 |
| 2019 | Guardant Health, Inc. (GH) | Chairman and Co-Chief Executive Officer | $500,000 | $914,906 |
| 2018 | Guardant Health, Inc. (GH) | Chief Executive Officer | $480,000 | $818,405 |
| 2017 | Guardant Health, Inc. (GH) | Chief Executive Officer | $460,000 | $4,136,113 |
